Soligenix, Inc. Registration Statement Declared Effective
Ticker: SNGX · Form: EFFECT · Filed: 2026-04-03T00:15:07-04:00
Sentiment: neutral
Topics: registration-statement, effectiveness, sec-filing
TL;DR
Soligenix EFFECT filing approved, registration statement is now effective.
AI Summary
Soligenix, Inc. filed an EFFECT form on April 3, 2026, indicating the effectiveness of a registration statement. The filing, with accession number 9999999995-26-001058, relates to Act 33 and File No. 333-276511. The effectiveness date was April 2, 2026.
Why It Matters
This filing signifies that Soligenix, Inc. has met the SEC's requirements for its registration statement, potentially paving the way for the sale of securities.
Risk Assessment
Risk Level: medium — Effectiveness of a registration statement is a procedural step, and the actual investment risk depends on the underlying securities and the company's financial health.
Key Numbers
- 2026-04-03 — Filing Date (Date the SEC accepted the filing.)
- 2026-04-02 — Effectiveness Date (Date the registration statement became effective.)
Key Players & Entities
- Soligenix, Inc. (company) — Filer
- 9999999995-26-001058 (dollar_amount) — SEC Accession Number
- 2026-04-03 (dollar_amount) — Filing Acceptance Date
- 2026-04-02 (dollar_amount) — Effectiveness Date
- 333-276511 (dollar_amount) — File Number
FAQ
What type of filing is this?
This is an EFFECT filing, indicating the effectiveness of a registration statement.
Who is the filer?
The filer is Soligenix, Inc. (CIK: 0000812796).
When was the filing accepted by the SEC?
The filing was accepted on 2026-04-03.
What is the effectiveness date mentioned in the filing?
The effectiveness date is 2026-04-02.
What is the file number associated with this registration statement?
The file number is 333-276511.
From the Filing
EDGAR Filing Documents for 9999999995-26-001058 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form EFFECT - Notice of Effectiveness: SEC Accession No. 9999999995-26-001058 Accepted 2026-04-03 00:15:07 Documents 1 Effectiveness Date 2026-04-02 Document Format Files Seq Description Document Type Size 1 primary_doc.html EFFECT 1 primary_doc.xml EFFECT 598 Complete submission text file 9999999995-26-001058.txt 2028 Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200 SOLIGENIX, INC. (Filer) CIK : 0000812796 (see all company filings) EIN. : 411505029 | State of Incorp.: DE | Fiscal Year End: 1231 Type: EFFECT | Act: 33 | File No.: 333-276511 | Film No.: 26836685 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)